Urinary tract infections (UTIs) are increasingly common in men, especially with age, posing serious health risks like blood ...

The top 5 infectious disease stories on AJMC.com this year covered both outbreaks and government-related developments. Bird ...

New French guidelines reshape care for urinary tract infections in men, dropping urine dipsticks, recognizing male cystitis, ...

US FDA approves GSK’s Blujepa as oral option for treatment of uncomplicated urogenital gonorrhoea: London, UK Saturday, December 13, 2025, 09:00 Hrs [IST] GSK plc announced that ...

A new rapid test could improve treatment of urinary tract infections, by identifying the most effective antibiotic for each ...

Researchers at the Technical University of Munich (TUM) have developed a method for diagnosing urinary tract infections that ...

UTIs are among the most common bacterial infections worldwide, but inappropriate use and overuse of antibiotics is driving ...

The FDA approved Nuzolvence (zoliflodacin) for uncomplicated urogenital gonorrhea in patients aged 12 years and older weighing at least 35kg.

The FDA expanded its approval of Addyi to treat low libido in postmenopausal women up to age 65. The approval will open up ...

The FDA has approved Blujepa for the treatment of uncomplicated urogenital gonorrhea caused by susceptible strains of Neisseria gonorrhoeae.

Overall survival data showed a 50% reduction in the risk of death with the regimen compared with surgery alone.